Alembic Net Income from 2010 to 2024
| APLLTD Stock | 1,042 4.00 0.39% |
Net Income | First Reported 2012-06-30 | Previous Quarter 1.3 B | Current Value 1.5 B | Quarterly Volatility 835.7 M |
Check Alembic Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alembic Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.9 B, Interest Expense of 590 M or Selling And Marketing Expenses of 5.1 B, as well as many indicators such as . Alembic financial statements analysis is a perfect complement when working with Alembic Pharmaceuticals Valuation or Volatility modules.
Alembic | Net Income |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Alembic Stock
Alembic Pharmaceuticals financial ratios help investors to determine whether Alembic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alembic with respect to the benefits of owning Alembic Pharmaceuticals security.